Image of a person at a white board with graphs and charts to show Janssen announces new results for subcutaneous formulation of DARZALEX ®▼ (Daratumumab) combination

Janssen’s results for subcutaneous formulation of DARZALEX ®▼ (Daratumumab) combination

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced results from the first randomised Phase 3 study investigating the subcutaneous formulation of DARZALEX®▼...
Imageof two heads communicating via speech bubble and text buble to show Kite receives EMA approval for CART-T cell therapy manufacturing facility

Kite receives EMA approval for CART-T cell therapy manufacturing facility

Kite receives European Medicines Agency (EMA) approval for CART-T cell therapy manufacturing facility in Europe. Kite, a Gilead Company has received approval to implement a...
Image of a document being signed to showNICE approves new rare lung cancer treatment from Roche

NICE approves new rare lung cancer treatment from Roche

The National Institute for Health and Care Excellence (NICE) has approved a new rare lung cancer treatment. NICE has published its decision to grant a...
Healthcare professional in PPE washing hands to show Janssen's COVID-19 vaccine trial to commence in July

Janssen’s COVID-19 vaccine trial to commence in July

Janssen's COVID-19 vaccine trial is to commence in the second half of July, earlier than expected. Johnson & Johnson has announced that through its...
Image of a laptop with medication, health charts and other symbols to show AstraZeneca to showcase new data on type-2 diabetes and cardiorenal complications

AstraZeneca to showcase new data on type-2 diabetes and cardiorenal complications

AstraZeneca is to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020. It will present new data from the landmark Phase III...
Image of a person sat in front of a number of digital icons to show Advancing digital technology in life sciences R&D and healthcare

Advancing digital technology in life sciences R&D and healthcare

The Pistoia Alliance launches new project to advance digital technology in life sciences R&D and healthcare to realise the value of digital health. The first...
Image of coronavirus to chow New study trials use of CT-P13 to accelerate COVID-19 recovery

New study trials use of CT-P13 to accelerate COVID-19 recovery

Celltrion Healthcare is partnering with the University of Oxford and University Hospitals Birmingham to study the use of CT-P13 (biosimilar infliximab) to accelerate COVID-19...
Image of a healthcare professional with a face mask to show Lilly announces start of a Phase 1 study for its second potential COVID-19 antibody treatment

Lilly announces start of a Phase 1 study for its second potential COVID-19 antibody...

Eli Lilly and Company announced that its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralising COVID-19...
Image of people lernng at a laptop, they are sat on the keys as chairs and the tutoe is point to the screen with charts and data to show Celltrion presents new data on subcutaneous formulation of infliximab

New data on subcutaneous formulation of infliximab

At the European E-Congress of Rheumatology 2020 (The European League Against Rheumatism (EULAR) 2020 E-Congress), Celltrion Healthcare showcased three sets of data relating to...
Image of pen and signature to show First adjuvanted quadrivalent influenza vaccine receives EU approval

First adjuvanted quadrivalent influenza vaccine receives EU approval

The European Commission has given regulatory approval for the first adjuvanted quadrivalent influenza vaccine to become available across Europe. This new vaccine builds on the...

Latest articles

Image of two business people shaking hands in front of a contract to show NICE recommends ADCETRIS (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a rare type of lymphoma

NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...

Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
Image of a briefcase and papers to show CMA formally concludes fludrocortisone investigation

CMA formally concludes fludrocortisone investigation

The Competition and Markets Authority (CMA) has formally concluded its fludrocortison investigation and found that three pharmaceutical companies took part in an illegal arrangement...
Image of a pharmacist holding tablets to show MHRA response to Independent Medicines and Medical Devices Safety Review

MHRA response to Independent Medicines and Medical Devices Safety Review

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its response to the Independent Medicines and Medical Devices Safety Review. In its response, the...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Graphic image of a woman watching a computer screen with a phone on it to show The ABPI Code & Virtual Promotional Meetings

The ABPI Code & Virtual Promotional Meetings

As the pharma industry looks to virtual meetings and teams work remotely, what considerations are there around the ABPI Code and virtual promotional meetings? Whilst...
IMage of a doctor and patient in front of a heart with trace to show First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations

First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations

The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has today published its report. Titled 'First Do No Harm', it comes...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Image of two business people shaking hands in front of a contract to show NICE recommends ADCETRIS (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a rare type of lymphoma

NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...

Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription